162 related articles for article (PubMed ID: 34769743)
1. Detection of Nail Oncometabolite SAICAR in Oral Cancer Patients and Its Molecular Interactions with PKM2 Enzyme.
Patel R; Raj AK; Lokhande KB; Almasri MA; Alzahrani KJ; Almeslet AS; Swamy KV; Sarode GS; Sarode SC; Patil S; Sharma NK
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769743
[TBL] [Abstract][Full Text] [Related]
2. SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.
Keller KE; Tan IS; Lee YS
Science; 2012 Nov; 338(6110):1069-72. PubMed ID: 23086999
[TBL] [Abstract][Full Text] [Related]
3. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells.
Keller KE; Doctor ZM; Dwyer ZW; Lee YS
Mol Cell; 2014 Mar; 53(5):700-9. PubMed ID: 24606918
[TBL] [Abstract][Full Text] [Related]
4. Succinyl-5-aminoimidazole-4-carboxamide-1-ribose 5'-Phosphate (SAICAR) Activates Pyruvate Kinase Isoform M2 (PKM2) in Its Dimeric Form.
Yan M; Chakravarthy S; Tokuda JM; Pollack L; Bowman GD; Lee YS
Biochemistry; 2016 Aug; 55(33):4731-6. PubMed ID: 27481063
[TBL] [Abstract][Full Text] [Related]
5. Reduced Level of Prolylhydroxyproline in the Nail Clippings of Oral Cancer Patients and its Role as an Activator of Phospholipase C-β2.
Bhatkar D; Nimburkar D; Raj AK; Lokhande KB; Khunteta K; Kothari H; Joshi M; Sarode SC; Sharma NK
Curr Protein Pept Sci; 2023; 24(8):684-699. PubMed ID: 37565551
[TBL] [Abstract][Full Text] [Related]
6. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
[TBL] [Abstract][Full Text] [Related]
7. Undetectable Free Aromatic Amino Acids in Nails of Breast Carcinoma: Biomarker Discovery by a Novel Metabolite Purification VTGE System.
Mitruka M; Gore CR; Kumar A; Sarode SC; Sharma NK
Front Oncol; 2020; 10():908. PubMed ID: 32695662
[No Abstract] [Full Text] [Related]
8. Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells.
Das MR; Bag AK; Saha S; Ghosh A; Dey SK; Das P; Mandal C; Ray S; Chakrabarti S; Ray M; Jana SS
BMC Cancer; 2016 Feb; 16():152. PubMed ID: 26911935
[TBL] [Abstract][Full Text] [Related]
9. Molecular docking analysis of pyruvate kinase M2 with a potential inhibitor from the ZINC database.
Sharma P; Singh M; Sharma S
Bioinformation; 2021; 17(1):139-146. PubMed ID: 34393429
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC).
Li RZ; Fan XX; Shi DF; Zhu GY; Wang YW; Luo LX; Pan HD; Yao XJ; Leung EL; Liu L
Chem Biol Drug Des; 2018 Nov; 92(5):1851-1858. PubMed ID: 29931766
[TBL] [Abstract][Full Text] [Related]
11. Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle.
Kapoor S; Chatterjee DR; Chowdhury MG; Das R; Shard A
Curr Drug Targets; 2023; 24(6):464-483. PubMed ID: 36998144
[TBL] [Abstract][Full Text] [Related]
12. Integrated In Silico-In Vitro Discovery of Lung Cancer-related Tumor Pyruvate Kinase M2 (PKM2) Inhibitors.
Ye X; Sun Y; Xu Y; Chen Z; Lu S
Med Chem; 2016; 12(7):613-620. PubMed ID: 26951145
[TBL] [Abstract][Full Text] [Related]
13. Allosteric regulation of PKM2 allows cellular adaptation to different physiological states.
Gui DY; Lewis CA; Vander Heiden MG
Sci Signal; 2013 Feb; 6(263):pe7. PubMed ID: 23423437
[TBL] [Abstract][Full Text] [Related]
14. An Intracellular Tripeptide Arg-His-Trp of Serum Origin Detected in MCF-7 Cells is a Possible Agonist to β2 Adrenoceptor.
Chandore H; Raj AK; Lokhande KB; Swamy KV; Pal JK; Sharma NK
Protein Pept Lett; 2021; 28(10):1191-1202. PubMed ID: 34397320
[TBL] [Abstract][Full Text] [Related]
15. In-Silico Analysis of Phytocompounds of
Qais FA; Alomar SY; Imran MA; Hashmi MA
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144527
[TBL] [Abstract][Full Text] [Related]
16. Identification of bioactive compounds of
Afzal M; Qais FA; Abduh NAY; Christy M; Ayub R; Alarifi A
Heliyon; 2024 Mar; 10(5):e27361. PubMed ID: 38495183
[TBL] [Abstract][Full Text] [Related]
17. 2'-hydroxycinnamaldehyde inhibits cancer cell proliferation and tumor growth by targeting the pyruvate kinase M2.
Yoon YJ; Kim YH; Jin Y; Chi SW; Moon JH; Han DC; Kwon BM
Cancer Lett; 2018 Oct; 434():42-55. PubMed ID: 30009856
[TBL] [Abstract][Full Text] [Related]
18. Molecular simulation of Tyr105 phosphorylated pyruvate kinase M2 to understand its structure and dynamics.
Kalaiarasan P; Subbarao N; Bamezai RN
J Mol Model; 2014 Sep; 20(9):2447. PubMed ID: 25208557
[TBL] [Abstract][Full Text] [Related]
19. Tumor M2-PK: A novel urine marker of bladder cancer.
Liu W; Woolbright BL; Pirani K; Didde R; Abbott E; Kaushik G; Martin P; Hamilton-Reeves J; Taylor JA; Holzbeierlein JM; Anant S; Lee EK
PLoS One; 2019; 14(6):e0218737. PubMed ID: 31246990
[TBL] [Abstract][Full Text] [Related]
20. New pyridin-3-ylmethyl carbamodithioic esters activate pyruvate kinase M2 and potential anticancer lead compounds.
Zhang Y; Liu B; Wu X; Li R; Ning X; Liu Y; Liu Z; Ge Z; Li R; Yin Y
Bioorg Med Chem; 2015 Aug; 23(15):4815-4823. PubMed ID: 26081759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
